Navigation Links
St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity
Date:5/12/2008

Immune cells adjust their function like a radio dial, not an on/off light switch; a discovery that hints at how autoimmune disease may develop late in life

MEMPHIS, Tenn., May 12 /PRNewswire-USNewswire/ -- A St. Jude Children's Research Hospital study shows that T cells, the body's master immune regulators, do not use simple on/off switches to govern the cellular machinery that regulates their development and function. Rather, they possess sophisticated molecular controls that enable them to adjust their function with exquisite precision. Such subtle adjustment enables T cells to modulate their development and function, including avoiding autoimmunity.

In autoimmune disease, rather than attacking invading microbes, the immune system attacks the body's own organs, tissues or cells. Some 80 autoimmune diseases are known, including type 1 diabetes, multiple sclerosis, rheumatoid arthritis and lupus.

"Among the many mysteries surrounding autoimmune diseases is why they can sometimes take decades to manifest themselves," said Dario Vignali, Ph.D., associate member in the St. Jude Department of Immunology. "Our findings hint that this delayed onset could be explained by subtle defects in the molecular controls on T cells." Such T cells are white blood cells whose duties include shutting down the immune system when it has done its job and suppressing T cells that can attack the body.

Vignali is the senior author of a report on this work that appears in the advance online publication of the journal "Nature Immunology."

The researchers explored the function of T cell receptors, proteins that span the cell membrane of T cells. These receptors receive outside signals that instruct T cells to develop, proliferate and transmit those signals into the cell. The St. Jude investigators sought to understand why T cell receptors need many copies of switch-like components called immunoreceptor tyrosine-based activation motifs (ITAMS).
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
2. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
3. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
4. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
6. Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
7. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
8. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
9. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
10. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
11. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...all/--BostonScientificCorporation(NYSE: BSX )issch...erence,December1-2. ,, RayElliott,PresidentandC...entandChiefFinancialOfficer,willparticipateina30-m...t,beginningatapproximately9:00a.m.E.T. ,, Alive...tedpartiesatBostonScientific,swebsiteat www.boston...
(Date:11/23/2009)...e-FirstCall/--TransceptPharmaceuticals,Inc.(Nasdaq...heU.S.FoodandDrugAdministration(FDA)onJanuary20,20...wDrugApplication(NDA)for Intermezzo ® (zolpi...,theCompleteResponseLetter,receivedbyTransceptonOc...NDAinitspresentform.TheNDAseeksapprovaltomarket In...
(Date:11/23/2009)...-FirstCall/--Amgen(Nasdaq: AMGN )washonoredwithtwo...rBestNewDrugforNplate®(romiplostim),ataNov.18...dwaspresentedtoAmgenbyScripinrecognitionofthesize,...eline,aswellasitsmixofcandidatesacrossdevelopments...eforitsfocusonunmetclinicalneed. ,, "Weareveryp...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6I Therapeutix Inc Announces Company Name Change 58217 1Physician Reimbursement and Their Practice Survival Defended by American National Medical Management 58214 1Physician Reimbursement and Their Practice Survival Defended by American National Medical Management 58214 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 1Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 3
(Date:11/24/2009)...ds no added use but higher costs , , TUE...er drug ads may contribute to higher Medicaid cost... the widely used antiplatelet drug clopidogrel (Pl... for 27 state Medicaid programs found that direct-...crease people,s use of the drug but appeared to be...
(Date:11/24/2009)...Newswire/--TheAmericanDentalAssociation(ADA)hassig...teammembersaspartofapilotprogramtoimprovetheoralhe...ntalHealthCoordinator(CDHC)isamemberofthedentalhea...tedaccesstodentalcaretoimprovetheiroralhealth. ,...areservices--includingscreeningsandfluoridetreatme...
(Date:11/24/2009)...gAK,AR,FL,IN,LA,ME,NE,NDandSD ,, ALEXANDRIA,Va...enate,svoteonSaturdaytotakeupthehealthcarereformle...vertisingcampaigntargetingSenatorsinninestates-Ala...ska,NorthDakota,andSouthDakota. ,, The$2.0milli...rvices(CMS)reportwhichconfirmscutstoMedicareofhalf...
(Date:11/24/2009)...--Metastorm,aleadingproviderofBusinessProcessManag...iseArchitecture(EA)softwareforaligningstrategywith...enCorporation,oneoftheworld,slargestpharmaceutical...icainthe2009GlobalAwardsforExcellenceinBusinessPro...ofMetastorm,sBPMsoftware.Theawardrecognizesorganiz...
(Date:11/24/2009)...re/--Thankstoaninnovativeprogramrecentlydevelopedb...BlueCrossandBlueShieldinMaine,someAnthemmembersinB...outleavinghome. ,, Aspartofthepilot,Anthemmembe...dcommunicateviaemailwiththeirprovideraboutnon-emer...kingontestresults,orrequestingprescriptionrefills....
Breaking Medicine News(10 mins):Health News:Advertising to Consumers May Raise Drug Prices 2Health News:ADA Launches Community Dental Health Coordinator Pilot Program at Temple University 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 2Health News:Senate Votes to Proceed - 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2Health News:The Doctor Will See You Now. . .Online 2
...GTON, Mass., Dec. 21 Palomar Medical,Technologies...developer of,light-based systems for cosmetic trea...ette Company (a wholly owned subsidiary of The Pro...ry 29,2008. Under the existing Development and Lic...
...LE, Calif., Dec. 21 The California Nurses,Associa...asted insurance,giant CIGNA for failing to approve...ld Nataline Sarkisyan, who tragically died last ni...the surgical director of,the Pediatric Liver Trans...
...F PRUSSIA, Pa., Dec. 21 CSL Behring today,announc...VIII (rFVIII),product for the treatment of hemophi...new 2000 IU (international unit) vial size. For pa... "Helixate FS, with the new 2000 IU vial, offers ...
...finds they lose about 4 points on IQ tests compare...(HealthDay News) -- Black children living in disad...of one year or more of schooling simply because of... in the division of developmental and behavioral p...
... and misprescribing can lead to overdose, death fr...ec. 21 (HealthDay News) -- For the second time in ...ports of deaths and dangerous side effects tied to...l. They are primarily used by cancer patients who ...
...ed Release of Several MRSA Related Products in our...RLES TOWN, W.Va., Dec. 21 ReBuilder,Medical Techn...tate of the,art electronic devices for diabetic pe.../cgi-bin/prnh/20061128/REBUILDERLOGO ), "We are ...
Other Medicine News:Health News:Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms 2Health News:Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms 3Health News:Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms 4Health News:RN's Statement on Death of Nataline Sarkisyan: 'CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago' 2Health News:CSL Behring's Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance 2Health News:CSL Behring's Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance 3Health News:Kids in Poor Neighborhoods Fall Behind in School 2Health News:FDA Renews Warnings on Pain-Relief Patch 2Health News:FDA Renews Warnings on Pain-Relief Patch 3Health News:FDA Renews Warnings on Pain-Relief Patch 4Health News:ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: